These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31205538)

  • 21. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
    Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
    Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies.
    Amendola LM; Muenzen K; Biesecker LG; Bowling KM; Cooper GM; Dorschner MO; Driscoll C; Foreman AKM; Golden-Grant K; Greally JM; Hindorff L; Kanavy D; Jobanputra V; Johnston JJ; Kenny EE; McNulty S; Murali P; Ou J; Powell BC; Rehm HL; Rolf B; Roman TS; Van Ziffle J; Guha S; Abhyankar A; Crosslin D; Venner E; Yuan B; Zouk H; ; Jarvik GP
    Am J Hum Genet; 2020 Nov; 107(5):932-941. PubMed ID: 33108757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignancies.
    Koeppel F; Muller E; Harlé A; Guien C; Sujobert P; Trabelsi Grati O; Kosmider O; Miguet L; Mauvieux L; Cayre A; Salgado D; Preudhomme C; Karayan-Tapon L; Tachon G; Coulet F; Lespagnol A; Beroud C; Leroy K; Rouleau E; Soubeyran I
    Eur J Cancer; 2021 Dec; 159():1-15. PubMed ID: 34700215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatic Tumor Variant Filtration Strategies to Optimize Tumor-Only Molecular Profiling Using Targeted Next-Generation Sequencing Panels.
    Sukhai MA; Misyura M; Thomas M; Garg S; Zhang T; Stickle N; Virtanen C; Bedard PL; Siu LL; Smets T; Thijs G; Van Vooren S; Kamel-Reid S; Stockley TL
    J Mol Diagn; 2019 Mar; 21(2):261-273. PubMed ID: 30576869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing.
    Dy GK; Nesline MK; Papanicolau-Sengos A; DePietro P; LeVea CM; Early A; Chen H; Grand'Maison A; Boland P; Ernstoff MS; Edge S; Akers S; Opyrchal M; Chatta G; Odunsi K; Pabla S; Conroy JM; Glenn ST; DeFedericis HT; Burgher B; Andreas J; Giamo V; Qin M; Wang Y; Kanehira K; Lenzo FL; Frederick P; Lele S; Galluzzi L; Kuvshinoff B; Morrison C
    BMC Med Inform Decis Mak; 2019 Jan; 19(1):14. PubMed ID: 30658646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatic and Germline BRCA 1 and 2 Mutations in Advanced NSCLC From the SAFIR02-Lung Trial.
    Remon J; Besse B; Leary A; Bièche I; Job B; Lacroix L; Auguste A; Mauduit M; Audigier-Valette C; Raimbourg J; Madroszyk A; Michels S; Bayar MA; Jimenez M; Soria JC; Rouleau E; Barlesi F
    JTO Clin Res Rep; 2020 Sep; 1(3):100068. PubMed ID: 34589950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy and reproducibility of somatic point mutation calling in clinical-type targeted sequencing data.
    Karimnezhad A; Palidwor GA; Thavorn K; Stewart DJ; Campbell PA; Lo B; Perkins TJ
    BMC Med Genomics; 2020 Oct; 13(1):156. PubMed ID: 33059707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variant Reinterpretation in Survivors of Cardiac Arrest With Preserved Ejection Fraction (the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry) by Clinicians and Clinical Commercial Laboratories.
    Davies B; Bartels K; Hathaway J; Xu F; Roberts JD; Tadros R; Green MS; Healey JS; Simpson CS; Sanatani S; Steinberg C; Gardner M; Angaran P; Talajic M; Hamilton R; Arbour L; Seifer C; Fournier A; Joza J; Krahn AD; Lehman A; Laksman ZWM
    Circ Genom Precis Med; 2021 Jun; 14(3):e003235. PubMed ID: 33960826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Somatic Curation and Interpretation Across Laboratories (SOCIAL) project-current state of solid-tumour variant interpretation for molecular pathology in Canada.
    Spence T; Sukhai MA; Kamel-Reid S; Stockley TL
    Curr Oncol; 2019 Dec; 26(6):353-360. PubMed ID: 31896933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shariant platform: Enabling evidence sharing across Australian clinical genetic-testing laboratories to support variant interpretation.
    Tudini E; Andrews J; Lawrence DM; King-Smith SL; Baker N; Baxter L; Beilby J; Bennetts B; Beshay V; Black M; Boughtwood TF; Brion K; Cheong PL; Christie M; Christodoulou J; Chong B; Cox K; Davis MR; Dejong L; Dinger ME; Doig KD; Douglas E; Dubowsky A; Ellul M; Fellowes A; Fisk K; Fortuno C; Friend K; Gallagher RL; Gao S; Hackett E; Hadler J; Hipwell M; Ho G; Hollway G; Hooper AJ; Kassahn KS; Krishnaraj R; Lau C; Le H; San Leong H; Lundie B; Lunke S; Marty A; McPhillips M; Nguyen LT; Nones K; Palmer K; Pearson JV; Quinn MCJ; Rawlings LH; Sadedin S; Sanchez L; Schreiber AW; Sigalas E; Simsek A; Soubrier J; Stark Z; Thompson BA; U J; Vakulin CG; Wells AV; Wise CA; Woods R; Ziolkowski A; Brion MJ; Scott HS; Thorne NP; Spurdle AB;
    Am J Hum Genet; 2022 Nov; 109(11):1960-1973. PubMed ID: 36332611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies for identification of somatic variants using the Ion Torrent deep targeted sequencing platform.
    Deshpande A; Lang W; McDowell T; Sivakumar S; Zhang J; Wang J; San Lucas FA; Fowler J; Kadara H; Scheet P
    BMC Bioinformatics; 2018 Jan; 19(1):5. PubMed ID: 29301485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.
    Li MM; Datto M; Duncavage EJ; Kulkarni S; Lindeman NI; Roy S; Tsimberidou AM; Vnencak-Jones CL; Wolff DJ; Younes A; Nikiforova MN
    J Mol Diagn; 2017 Jan; 19(1):4-23. PubMed ID: 27993330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinically impactful differences in variant interpretation between clinicians and testing laboratories: a single-center experience.
    Bland A; Harrington EA; Dunn K; Pariani M; Platt JCK; Grove ME; Caleshu C
    Genet Med; 2018 Mar; 20(3):369-373. PubMed ID: 29240077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Data sharing as a national quality improvement program: reporting on BRCA1 and BRCA2 variant-interpretation comparisons through the Canadian Open Genetics Repository (COGR).
    Lebo MS; Zakoor KR; Chun K; Speevak MD; Waye JS; McCready E; Parboosingh JS; Lamont RE; Feilotter H; Bosdet I; Tucker T; Young S; Karsan A; Charames GS; Agatep R; Spriggs EL; Chisholm C; Vasli N; Daoud H; Jarinova O; Tomaszewski R; Hume S; Taylor S; Akbari MR; Lerner-Ellis J;
    Genet Med; 2018 Mar; 20(3):294-302. PubMed ID: 28726806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted RNA sequencing for upfront analysis of actionable driver alterations in non-small cell lung cancer.
    Claerhout S; Lehnert S; Vander Borght S; Spans L; Dooms C; Wauters E; Vansteenkiste J; Weynand B; Deraedt K; Bourgain C; Vanden Bempt I
    Lung Cancer; 2022 Apr; 166():242-249. PubMed ID: 35378489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
    Park S; Olsen S; Ku BM; Lee MS; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Ahn MJ
    Cancer; 2021 Aug; 127(16):3019-3028. PubMed ID: 33826761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer gene profiling in non-small cell lung cancers reveals activating mutations in JAK2 and JAK3 with therapeutic implications.
    Li SD; Ma M; Li H; Waluszko A; Sidorenko T; Schadt EE; Zhang DY; Chen R; Ye F
    Genome Med; 2017 Oct; 9(1):89. PubMed ID: 29082853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotypic analysis of a large cohort of patients with suspected atypical hemolytic uremic syndrome.
    Connaughton DM; Bhai P; Isenring P; Mahdi M; Sadikovic B; Schenkel LC
    J Mol Med (Berl); 2023 Aug; 101(8):1029-1040. PubMed ID: 37466676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
    Pécuchet N; Legras A; Laurent-Puig P; Blons H
    Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies.
    Fisher KE; Zhang L; Wang J; Smith GH; Newman S; Schneider TM; Pillai RN; Kudchadkar RR; Owonikoko TK; Ramalingam SS; Lawson DH; Delman KA; El-Rayes BF; Wilson MM; Sullivan HC; Morrison AS; Balci S; Adsay NV; Gal AA; Sica GL; Saxe DF; Mann KP; Hill CE; Khuri FR; Rossi MR
    J Mol Diagn; 2016 Mar; 18(2):299-315. PubMed ID: 26801070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.